Ursprung des Netzwerks ersten Grades von Gevorg Grigoryan
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018.
13
| Holding Company | Biotechnology | 13 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Gevorg Grigoryan
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Chief Executive Officer Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Analyst Chief Executive Officer | |
Massachusetts Institute of Technology | College/University | Director/Board Member Doctorate Degree Doctorate Degree Undergraduate Degree | |
University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Founder Founder Founder | |
McGill University | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
AXCA HEALPAR | Biotechnology | Founder Founder Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin | |
Indigo Ag, Inc.
Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Biotechnology | Founder Director/Board Member Founder | |
BG MEDICINE, INC. | Medical Specialties | Founder Chairman | |
Tessera Therapeutics, Inc.
Tessera Therapeutics, Inc. BiotechnologyHealth Technology Tessera Therapeutics, Inc. engages in science company. It offers scientists and doctors the ability to write and rewrite small and large therapeutic messages into the genome, thereby curing diseases at their source. The company is headquartered in Cambridge, MA. | Biotechnology | Founder Director/Board Member | |
Profound Therapeutics
Profound Therapeutics Pharmaceuticals: OtherHealth Technology Profound Therapeutics is a company that is focused on discovering new medicines by expanding the human proteome. The company is based in Cambridge, MA. The company uses their platform, Profoundry, to identify and validate proteins and understand their therapeutic potential. This results in a growing database of novel proteins and their roles in health and disease. The company was founded in 2020 by Avak Kahvejian, who has been the CEO since then. | Pharmaceuticals: Other | Chairman Chief Executive Officer | |
SERES THERAPEUTICS, INC. | Biotechnology | Founder Founder | |
Ampersand Biomedicines
Ampersand Biomedicines BiotechnologyHealth Technology Ampersand Biomedicines is an American company that designs programmable medicines that work precisely where needed in the body and nowhere else. The company's computationally powered platform identifies ideal addresses for drug localization and informs the design of and-body™ therapeutics that have the optimal therapeutic effect. The result is smarter biologic medicines that target the site of disease without affecting healthy tissue or cells. Ampersand is enabling potent mechanisms to treat disease by creating and programming therapeutics that are more efficacious, without compromising on safety or tolerability. The company was founded in 2020 at Flagship Labs, a unit of Flagship Pioneering. Jason Gardner has been the CEO of the company since 2023. | Biotechnology | Founder Founder | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
RUBIUS THERAPEUTICS | Biotechnology | Founder Founder | |
Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Founder Founder | |
Cobalt Biomedicine, Inc.
Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Cobalt Biomedicine, Inc. engages in the development of therapeutic based drugs. The company was founded in 2017 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
CODIAK BIOSCIENCES | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Cygnal Therapeutics, Inc.
Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Founder Founder | |
SANA BIOTECHNOLOGY, INC. | Biotechnology | Founder Director/Board Member | |
MODERNA, INC. | Biotechnology | Founder Chief Executive Officer | |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The National Academies of Science
The National Academies of Science Miscellaneous Commercial ServicesCommercial Services The National Academies of Science operates as a private non-profit organization that provides advice in sciences, engineering and medicine. It conducted through seven major program areas: Behavioral and Social Sciences and Education, Earth and Life Studies, Engineering and Physical Sciences, Health and Medicine, Policy and Global Affairs, Transportation Research Board, and the Gulf Research Program. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Donna & Benjamin M Rosen Bioengineering Center | Director/Board Member | ||
GEVO, INC. | Chemicals: Specialty | Founder | |
ILLUMINA, INC. | Biotechnology | Director/Board Member | |
Eli Lilly & Co. Ltd.
Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Eli Lilly & Co. Ltd. provides pharmaceutical health care solutions. It provide products for cardiovascular, dermatology, diabetes, endocrine, musculoskeletal, neuroscience, oncology and urology. The company was incorporated on April 9, 1963 and is headquartered in Basingstoke, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
QIAGEN N.V. | Medical Specialties | Director/Board Member | |
SYROS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
BIOMÉRIEUX | Medical Specialties | Chief Executive Officer | |
Eli Lilly Benelux SA
Eli Lilly Benelux SA Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Benelux SA is a pharmaceutical company based in Brussels, Belgium. The Belgian company focuses on research and development to discover and offer innovative medicines that improve the quality of life for people worldwide. Lilly has established policies, standards, and protective measures for the entire research and development process to ensure that the patient remains the top priority. The CEO of the company is Frederic Clais. | Pharmaceuticals: Major | Corporate Officer/Principal | |
QIAGEN GmbH
QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
Provivi, Inc.
Provivi, Inc. Chemicals: AgriculturalProcess Industries Provivi, Inc. develops biopesticides for agriculture, commercial, household, and public health pest management. The company was founded by Pedro S. L. Coelho, Peter Meinhold and Frances Arnold in 2013 and is headquartered in Santa Monica, CA. | Chemicals: Agricultural | Founder | |
Museum of Science
Museum of Science Other Consumer ServicesConsumer Services Museum of Science operates as a museum. The company was founded in 1830 and is headquartered in Boston, MA. | Other Consumer Services | Director/Board Member | |
Qiagen SRL
Qiagen SRL Medical SpecialtiesHealth Technology Qiagen SRL is engaged in providing assay technologies. The company is headquartered in Milan, Italy. | Medical Specialties | Director/Board Member | |
Moderna SpA
Moderna SpA Food DistributorsDistribution Services Moderna SpA is an Italian company that provides information, products, and services through their e-modern.com website. The private company is based in Salerno, Italy. The company has a product catalog, a cash area, and a delivery director. The CEO of the company is Stéphane Bancel. | Food Distributors | Chief Executive Officer | |
Moderna Holding BV
Moderna Holding BV MiscellaneousMiscellaneous Part of Elis SA, Moderna Holding BV is an investment holding Dutch company. The company is based in Hardenberg, the Netherlands. Moderna Holding was acquired by Elis SA on March 01, 2024. | Miscellaneous | Chief Executive Officer | |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Director/Board Member | |
ALPHABET INC. | Internet Software/Services | Director/Board Member | |
Tafkak, Inc.
Tafkak, Inc. Miscellaneous Commercial ServicesCommercial Services Tafkak, Inc. provides genome sequencing and analysis solutions. It offers tools and solutions to researchers, drug developers and clinicians determine the genetic basis of human disease and drug response. The firm provides knomeCLINIC a software suite that helps medical researchers and clinicians interpret human genomes for biological relevance; kGAP a cloud-enabled genome informatics engine that automates the process of standardizing, distilling, annotating and comparing sequence data. It also offers knomeVARIANTS, a discovery-supportive interpretation tool, which helps researchers to find causal variants and genes. The company was founded by Jorge Conde and George M. Church in 2007 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member | |
National Academy of Engineering
National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Part of The National Academies of Science, the National Academy of Engineering operates as a professional membership organization. The company is based in Washington. | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistik
International
Vereinigte Staaten | 42 |
Niederlande | 3 |
Italien | 3 |
Kanada | 2 |
Vereinigtes Königreich | 2 |
Sektoral
Health Technology | 27 |
Commercial Services | 10 |
Consumer Services | 7 |
Finance | 3 |
Process Industries | 3 |
Operativ
Director/Board Member | 110 |
Founder | 63 |
Corporate Officer/Principal | 29 |
Chairman | 24 |
Chief Executive Officer | 20 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Noubar Afeyan | 76 |
Stéphane Bancel | 23 |
Frances Arnold | 20 |
Jane Mendillo | 16 |
Geoffrey von Maltzahn | 15 |
Avak Kahvejian | 13 |
Gary Pisano | 11 |
Michael Nohaile | 9 |
Michael Nally | 9 |
Poorya Hosseini | 7 |
Grace Larry | 7 |
Snyder Alexandra | 4 |
Molly Gibson | 3 |
- Börse
- Insiders
- Gevorg Grigoryan
- Unternehmensverbindungen